Dr Louise   Emmett
Conjoint Professor

Dr Louise Emmett

INSTITUTION AND LOCATION

DEGREE

(if applicable)

 

Completion Date

MM/YYYY

 

FIELD OF STUDY

 

University of Auckland

BSc(HONS)

1989

Medicine

University of Auckland

 

MBChB

 

1991

 

Medicine

Royal North Shore Hospital, Australia

 

1992-1996

Internship, General Medicine/Surgery

The Royal Australasian College of Physicians, Australia

FRACP

1996-1999

Medical Residency, Medicine

Toronto Western Hospital, Toronto, Canada

 

2000-2001

Nuclear medicine Fellow

Staff Specialist Nuclear Medicine, Concord Hospital, Sydney

FAANMS

2001-2012

 

Auckland University

MD

2014 completed

 

Thesis in Nuclear Cardiology

 

medicine-health
St Vincent's Clinical School

INSTITUTION AND LOCATION

DEGREE

(if applicable)

 

Completion Date

MM/YYYY

 

FIELD OF STUDY

 

University of Auckland

BSc(HONS)

1989

Medicine

University of Auckland

 

MBChB

 

1991

 

Medicine

Royal North Shore Hospital, Australia

 

1992-1996

Internship, General Medicine/Surgery

The Royal Australasian College of Physicians, Australia

FRACP

1996-1999

Medical Residency, Medicine

Toronto Western Hospital, Toronto, Canada

 

2000-2001

Nuclear medicine Fellow

Staff Specialist Nuclear Medicine, Concord Hospital, Sydney

FAANMS

2001-2012

 

Auckland University

MD

2014 completed

 

Thesis in Nuclear Cardiology

 

A.        Personal Statement

 

The advent of small molecule peptide imaging and therapy is changing the face of oncology diagnosis, prognosis and treatment. This has had a dramatic effect in prostate cancer, with a paradigm shift in clinical practice. At the forefront of this shift in clinical practice, St Vincent’s commenced multiple imaging and therapy trials in prostate cancer using GaPSMA PET and LuPSMA therapy between 2014 and 2018. Having made the move from Nuclear Cardiology in 2012 (culminating in an MD based on publications in the field), to theranostics was a personal paradigm shift in focus that co-incided with the disruptive technology taking place. It has been an incredible opportunity to explore a new weapon in the armament against cancer, well before the rest of the world.

Our prospective trials in LuPSMA therapy, into the diagnostic and prognostic value of PSMA PET and into the manipulability of the PSMA receptor in response to androgen blockade, have been practice changing

Publications

  • Book Chapters | 2011
    Dr Louise Emmett
    Wong T; Girgis CM; Ngu MC; Chen RCY; Emmett L; Archer KA; Seibel MJ, 2011, '13. A 40-year-old Man with Widespread Bone Pain', in Diagnostic Dilemmas: Images in Endocrinology, The Endocrine Society, pp. 74 - 78, http://dx.doi.org/10.1210/dde1.9781936704583.ch13
    Book Chapters | 2004
    Dr Louise Emmett
    Emmett L, 2004, 'Vascular Manifestations. Chapter 48.', in Nuclear medicine in clinical diagnosis and treatment., pp. 693 - 707
  • Journal articles | 2021
    Dr Louise Emmett
    Dhiantravan N; Emmett L; Joshua AM; Pattison DA; Francis RJ; Williams S; Sandhu S; Davis ID; Vela I; Neha N; Bressel M; Murphy DG; Hofman MS; Azad AA, 2021, 'UpFrontPSMA: a randomized phase 2 study of sequential 177Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)', BJU International, http://dx.doi.org/10.1111/bju.15384
    Journal articles | 2021
    Dr Louise Emmett
    Hofman MS; Emmett L; Sandhu S; Iravani A; Joshua AM; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Ng S; Francis RJ; Gedye C; Rutherford NK; Weickhardt A; Scott AM; Lee ST; Kwan EM; Azad AA; Ramdave S; Redfern AD; Macdonald W; Guminski A; Hsiao E; Chua W; Lin P; Zhang AY; McJannett MM; Stockler MR; Violet JA; Williams SG; Martin AJ; Davis ID; Dhiantravan N; Ford K; Langford A; Lawrence N; McDonald W; Rana N; Subramaniam S; Yip S, 2021, '[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial', The Lancet, vol. 397, pp. 797 - 804, http://dx.doi.org/10.1016/S0140-6736(21)00237-3
    Journal articles | 2021
    Dr Louise Emmett
    Mei R; Bracarda S; Emmett L; Farolfi A; Lambertini A; Fanti S; Castellucci P, 2021, 'Androgen deprivation therapy and its modulation of PSMA expression in prostate cancer: mini review and case series of patients studied with sequential [68Ga]-Ga-PSMA-11 PET/CT', Clinical and Translational Imaging, vol. 9, pp. 215 - 220, http://dx.doi.org/10.1007/s40336-021-00421-4
    Journal articles | 2021
    Dr Louise Emmett
    Lawhn-Heath C; Salavati A; Behr SC; Rowe SP; Calais J; Fendler WP; Eiber M; Emmett L; Hofman MS; Hope TA, 2021, 'Prostate-specific membrane antigen PET in prostate cancer', Radiology, vol. 299, pp. 248 - 260, http://dx.doi.org/10.1148/RADIOL.2021202771
    Journal articles | 2021
    Dr Louise Emmett
    Liu W; Zukotynski K; Emmett L; Chung HT; Chung P; Wolfson R; Rachinsky I; Kapoor A; Metser U; Loblaw A; Morton G; Sexton T; Lock M; Helou J; Berlin A; Boylan C; Archer S; Pond GR; Bauman G, 2021, 'Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging', Advances in Radiation Oncology, vol. 6, http://dx.doi.org/10.1016/j.adro.2020.08.010
    Journal articles | 2021
    Dr Louise Emmett
    Bagguley D; Ong S; Buteau JP; Koschel S; Dhiantravan N; Hofman MS; Emmett L; Murphy DG; Lawrentschuk N, 2021, 'Role of PSMA PET/CT imaging in the diagnosis, staging and restaging of prostate cancer', Future Oncology, vol. 17, pp. 2225 - 2241, http://dx.doi.org/10.2217/fon-2020-1293
    Journal articles | 2021
    Dr Louise Emmett
    Luiting HB; Remmers S; Meijer D; Vis AN; Donswijk M; Oprea-Lager DE; Emmett L; Rauscher I; Van der Poel HG; Roobol MJ; van Leeuwen PJ, 2021, 'External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?', European Urology Open Science, vol. 28, pp. 47 - 51, http://dx.doi.org/10.1016/j.euros.2021.04.002
    Journal articles | 2021
    Dr Louise Emmett
    Long GV; Atkinson V; Lo S; Guminski AD; Sandhu SK; Brown MP; Gonzalez M; Scolyer RA; Emmett L; McArthur GA; Menzies AM, 2021, 'Five-year overall survival from the anti-PD1 brain collaboration (ABC Study): Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets).', Journal of Clinical Oncology, vol. 39, pp. 9508 - 9508, http://dx.doi.org/10.1200/jco.2021.39.15_suppl.9508
    Journal articles | 2021
    Dr Louise Emmett
    Emmett L; Subramaniam S; Joshua AM; Crumbaker M; Martin A; Zhang AY; Rana N; Langford A; Mitchell J; Yip S; Francis R; Hofman MS; Sandhu S; Azad A; Gedye C; McJannett M; Stockler MR; Davis ID, 2021, 'ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901)', BJU International, http://dx.doi.org/10.1111/bju.15491
    Journal articles | 2021
    Dr Louise Emmett
    Ceci F; Oprea-Lager DE; Emmett L; Adam JA; Bomanji J; Czernin J; Eiber M; Haberkorn U; Hofman MS; Hope TA; Kumar R; Rowe SP; Schwarzenboeck SM; Fanti S; Herrmann K, 2021, 'E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, pp. 1626 - 1638, http://dx.doi.org/10.1007/s00259-021-05245-y
    Journal articles | 2021
    Dr Louise Emmett
    Turner RM; Dieng M; Khanna N; Nguyen M; Zeng J; Nijhuis AAG; Nieweg OE; Einstein AJ; Emmett L; Lord SJ; Menzies AM; Thompson JF; Saw RPM; Morton RL, 2021, 'Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma', Annals of Surgical Oncology, vol. 28, pp. 4561 - 4569, http://dx.doi.org/10.1245/s10434-020-09270-3
    Journal articles | 2021
    Dr Louise Emmett
    Meijer D; van Leeuwen PJ; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Oprea-Lager DE; Coughlin GD; Vis AN, 2021, 'External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study', European Urology, http://dx.doi.org/10.1016/j.eururo.2021.05.006
    Journal articles | 2021
    Dr Louise Emmett
    Roberts MJ; Morton A; Donato P; Kyle S; Pattison DA; Thomas P; Coughlin G; Esler R; Dunglison N; Gardiner RA; Doi SA; Emmett L; Yaxley J, 2021, '68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, pp. 477 - 482, http://dx.doi.org/10.1007/s00259-020-04944-2
    Journal articles | 2021
    Dr Louise Emmett
    Roberts MJ; Morton A; Donato P; Kyle S; Pattison DA; Thomas P; Coughlin G; Esler R; Dunglison N; Gardiner RA; Doi SA; Emmett L; Yaxley J, 2021, 'Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 48, 2, (477-482), 10.1007/s00259-020-04944-2)', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, pp. 655 - 656, http://dx.doi.org/10.1007/s00259-020-04983-9
    Journal articles | 2021
    Dr Louise Emmett
    De Bono J; Delaney E; Emmett L; Florisson D; Ghani M; Kemp S; Smith J, 2021, 'M13 Cardiac Surgery Advanced Life Support – A Unique Approach and Learning Program', Heart, Lung and Circulation, vol. 30, pp. S6 - S7, http://dx.doi.org/10.1016/j.hlc.2021.03.022
    Journal articles | 2021
    Dr Louise Emmett
    Ende J; Amin A; Sheehan-Dare G; Cusick T; Ho B; Keane J; Nguyen A; Liu V; Lee J; Chan L; Chen A; Fullard K; Stricker P; Emmett L, 2021, 'Pilot Trial Comparing the Performance of 68Ga-PSMA-11 PET/CT to 18F-PSMA-1007 PET/ CT in the Detection of Prostate Cancer Recurrence in Men with Rising PSA Following Radical Prostatectomy', Journal of Radiology and Medical Imaging, https://meddocsonline.org/journal-of-radiology-and-medical-imaging/pilot-trial-comparing-the-performance-of-68Ga-PSMA-11-PET-CT-to-18F-PSMA-1007-PET-CT-in-the-detection-of-prostate-cancer-recurrence-in-men-with-rising-PSA-following-radical-prostatectomy.pdf
    Journal articles | 2020
    Dr Louise Emmett
    Liu W; Zukotynski K; Emmett L; Chung HT; Chung P; Wolfson R; Rachinsky I; Kapoor A; Metser U; Loblaw A; Morton G; Sexton T; Lock M; Helou J; Berlin A; Boylan C; Archer S; Pond GR; Bauman G, 2020, 'A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy', International Journal of Radiation Oncology Biology Physics, vol. 106, pp. 546 - 555, http://dx.doi.org/10.1016/j.ijrobp.2019.11.001
    Journal articles | 2020
    Dr Louise Emmett
    Emmett L; Tang R; Nandurkar R; Hruby G; Roach P; Watts JA; Cusick T; Kneebone A; Ho B; Chan L; van Leeuwen PJ; Scheltema MJ; Nguyen A; Yin C; Scott A; Tang C; McCarthy M; Fullard K; Roberts M; Francis R; Stricker P, 2020, '3-Year Freedom from Progression After 68Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 61, pp. 866 - 872, http://dx.doi.org/10.2967/jnumed.119.235028
    Journal articles | 2020
    Dr Louise Emmett
    Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ, 2020, 'Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature', BJU International, vol. 125, pp. 206 - 214, http://dx.doi.org/10.1111/bju.14944
    Journal articles | 2020
    Dr Louise Emmett
    Hofman MS; Emmett L; Sandhu SK; Iravani A; Joshua AM; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Ng S; Francis RJ; Gedye C; Rutherford NK; Zhang AY; McJannett MM; Stockler MR; Violet JA; Williams S; Martin AJ; Davis ID, 2020, 'TheraP: A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) progressing after docetaxel: Initial results (ANZUP protocol 1603).', Journal of Clinical Oncology, vol. 38, pp. 5500 - 5500, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.5500
    Journal articles | 2020
    Dr Louise Emmett
    Holtkamp LHJ; Chakera AH; Fung S; Stretch JR; Saw RPM; Lee K; Ch'Ng S; Gonzalez M; Thompson JF; Emmett L; Nieweg OE, 2020, 'Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases', Melanoma Research, vol. 30, pp. 358 - 363, http://dx.doi.org/10.1097/CMR.0000000000000666
    Journal articles | 2020
    Dr Louise Emmett
    Fendler WP; Calais J; Eiber M; Simko JP; Kurhanewicz J; Santos RD; Feng FY; Reiter RE; Rettig MB; Nickols NG; Kishan AU; Shozo O; Emmett L; Zacho HD; Ilhan H; Rischpler C; Wetter A; Schoder H; Burger IA; Slavik R; Carroll PR; Lawhn-Heath C; Herrmann K; Czernin J; Hope TA, 2020, 'False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial', European Journal of Nuclear Medicine and Molecular Imaging, http://dx.doi.org/10.1007/s00259-020-04945-1
    Journal articles | 2020
    Dr Louise Emmett
    Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L, 2020, 'Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer', BJU International, vol. 125, pp. 515 - 524, http://dx.doi.org/10.1111/bju.14999
    Journal articles | 2020
    Dr Louise Emmett
    Lee J; Emmett L; Tang R; Ho B; Earls P; Matthews T; Gallagher R, 2020, 'Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma', ANZ Journal of Surgery, vol. 90, pp. 1396 - 1401, http://dx.doi.org/10.1111/ans.16093
    Journal articles | 2020
    Dr Louise Emmett
    Crumbaker M; Pathmanandavel S; Yam AO; Nguyen A; Ho B; Chan L; Ende JA; Rofe C; Kongrak K; Kwan EM; Azad AA; Sharma S; Pugh TJ; Danesh A; Keane J; Eu P; Joshua AM; Emmett L, 2020, 'Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN).', Eur Urol Oncol, http://dx.doi.org/10.1016/j.euo.2020.07.002
    Journal articles | 2020
    Dr Louise Emmett
    Emmett L; Hofman MS, 2020, 'Editorial Comment', The Journal of urology, vol. 203, pp. 99, http://dx.doi.org/10.1097/01.JU.0000605568.03568.2c
    Journal articles | 2020
    Dr Louise Emmett
    Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ, 2020, 'Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection', BJU International, vol. 125, pp. 876 - 883, http://dx.doi.org/10.1111/bju.15052
    Journal articles | 2020
    Dr Louise Emmett
    Emmett L; Hruby G, 2020, 'Clinical impact of PET imaging in prostate cancer management', Current opinion in urology, vol. 30, pp. 649 - 653, http://dx.doi.org/10.1097/MOU.0000000000000795
    Journal articles | 2020
    Dr Louise Emmett
    Emmett L; Pathmanandavel S; Nguyen A; Crumbaker M; Yam AOW; Chan WL; Fullard K; Ho B; Azad A; Joshua AM, 2020, 'Results of a phase I/II prospective dose-escalation trial evaluating safety and efficacy of combination 177LuPSMA-617 and NOX66 in men with mCRPC post androgen signalling inhibition and two lines of taxane chemotherapy (LuPIN trial).', Journal of Clinical Oncology, vol. 38, pp. 120 - 120, http://dx.doi.org/10.1200/jco.2020.38.6_suppl.120
    Journal articles | 2020
    Dr Louise Emmett
    Emmett L; Pathmanandavel S; Crumbaker M; Rofe C; Yam AOW; Ho B; Chan WL; Sharma S; Keane J; Hickey AJ; Fullard K; Kongrak K; Ratnayake L; Violet JA; Azad A; Eu P; Nguyen A; Joshua AM, 2020, 'Updated results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and idronoxil in men with mCRPC post androgen signalling inhibition and taxane chemotherapy (LuPIN trial).', Journal of Clinical Oncology, vol. 38, pp. 5557 - 5557, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.5557
    Journal articles | 2020
    Dr Louise Emmett
    Emmett L, 2020, 'Changing the Goal Posts: Prostate-specific Membrane Antigen Targeted Theranostics in Prostate Cancer', Seminars in Oncology Nursing, http://dx.doi.org/10.1016/j.soncn.2020.151052
    Journal articles | 2019
    Dr Louise Emmett
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L, 2019, 'Gallium-68-prostate-specific membrane antigen (68Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer', BJU International, vol. 124, pp. 62 - 68, http://dx.doi.org/10.1111/bju.14506
    Journal articles | 2019
    Dr Louise Emmett
    Metser U; Chua S; Ho B; Punwani S; Johnston E; Pouliot F; Tau N; Hawsawy A; Anconina R; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Pond G; Scott AM; Tunariu N; Sidhu H; Emmett L, 2019, 'The contribution of multiparametric pelvic and whole-body MRI to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure after radical prostatectomy', Journal of Nuclear Medicine, vol. 60, pp. 1253 - 1258, http://dx.doi.org/10.2967/jnumed.118.225185
    Journal articles | 2019
    Dr Louise Emmett
    Nandurkar R; Van Leeuwen P; Stricker P; Woo H; Kooner R; Yuen C; O'Neill G; Ende D; Cusick T; Ho B; Hickey A; Emmett L, 2019, '68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery', British Journal of Radiology, vol. 92, pp. 20180667, http://dx.doi.org/10.1259/bjr.20180667
    Journal articles | 2019
    Dr Louise Emmett
    Hofman MS; Emmett L, 2019, 'Tumour Heterogeneity and Resistance to Therapy in Prostate Cancer: A Fundamental Limitation of Prostate-specific Membrane Antigen Theranostics or a Key Strength?', European Urology, vol. 76, pp. 479 - 481, http://dx.doi.org/10.1016/j.eururo.2019.07.030
    Journal articles | 2019
    Dr Louise Emmett
    Fendler WP; Calais J; Eiber M; Flavell RR; Mishoe A; Feng FY; Nguyen HG; Reiter RE; Rettig MB; Okamoto S; Emmett L; Zacho HD; Ilhan H; Wetter A; Rischpler C; Schoder H; Burger IA; Gartmann J; Smith R; Small EJ; Slavik R; Carroll PR; Herrmann K; Czernin J; Hope TA, 2019, 'Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial', JAMA Oncology, vol. 5, pp. 856 - 863, http://dx.doi.org/10.1001/jamaoncol.2019.0096
    Journal articles | 2019
    Dr Louise Emmett
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L, 2019, 'Diagnostic accuracy of 68Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68Ga-PSMA PET to mpMRI', BJU International, vol. 124, pp. 42 - 49, http://dx.doi.org/10.1111/bju.14794
    Journal articles | 2019
    Dr Louise Emmett
    Long GV; Saw RPM; Lo S; Nieweg OE; Shannon KF; Gonzalez M; Guminski A; Lee JH; Lee H; Ferguson PM; Rawson RV; Wilmott JS; Thompson JF; Kefford RF; Ch'ng S; Stretch JR; Emmett L; Kapoor R; Rizos H; Spillane AJ; Scolyer RA; Menzies AM, 2019, 'Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial', The Lancet Oncology, vol. 20, pp. 961 - 971, http://dx.doi.org/10.1016/S1470-2045(19)30331-6
    Journal articles | 2019
    Dr Louise Emmett
    Yin C; Ho B; Chan L; Emmett L, 2019, 'Asymptomatic Prostate Cancer Brain Metastases on 68Ga-PSMA PET/CT', Clinical Nuclear Medicine, vol. 44, pp. E382 - E384, http://dx.doi.org/10.1097/RLU.0000000000002548
    Journal articles | 2019
    Dr Louise Emmett
    Emmett L; Metser U; Bauman G; Hicks RJ; Weickhardt A; Davis ID; Punwani S; Pond G; Chua S; Ho B; Johnston E; Pouliot F; Scott AM, 2019, 'Prospective, multisite, international comparison of 18F-fluoromethylcholine PET/CT, multiparametric MRI, and 68Ga-HBED-CC PSMA-11 PET/CT in men with high-risk features and biochemical failure after radical prostatectomy: Clinical performance and patient outcomes', Journal of Nuclear Medicine, vol. 60, pp. 794 - 800, http://dx.doi.org/10.2967/jnumed.118.220103
    Journal articles | 2019
    Dr Louise Emmett
    Hofman MS; Emmett L; Violet J; Y. Zhang A; Lawrence NJ; Stockler M; Francis RJ; Iravani A; Williams S; Azad A; Martin A; McJannett M; Davis ID, 2019, 'TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)', BJU International, vol. 124, pp. 5 - 13, http://dx.doi.org/10.1111/bju.14876
    Journal articles | 2019
    Dr Louise Emmett
    Long GV; Atkinson VG; Lo S; Sandhu SK; Brown M; Gonzalez M; Guminski A; Scolyer RA; Emmett L; Menzies AM; McArthur GA, 2019, 'Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 brain collaboration (ABC)', Annals of Oncology, vol. 30, pp. v534 - v534, http://dx.doi.org/10.1093/annonc/mdz255.001
    Journal articles | 2019
    Dr Louise Emmett
    Lieng H; Kneebone A; Hayden AJ; Christie DRH; Davis BJ; Eade TN; Emmett L; Holt T; Hruby G; Pryor D; Sidhom M; Skala M; Yaxley J; Shakespeare TP, 2019, 'Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group', Radiotherapy and Oncology, vol. 140, pp. 68 - 75, http://dx.doi.org/10.1016/j.radonc.2019.05.016
    Journal articles | 2019
    Dr Louise Emmett
    Emmett L; Crumbaker M; Ho B; Willowson K; Eu P; Ratnayake L; Epstein R; Blanksby A; Horvath L; Guminski A; Mahon K; Gedye C; Yin C; Stricker P; Joshua AM, 2019, 'Results of a Prospective Phase 2 Pilot Trial of 177 Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression', Clinical Genitourinary Cancer, vol. 17, pp. 15 - 22, http://dx.doi.org/10.1016/j.clgc.2018.09.014
    Journal articles | 2019
    Dr Louise Emmett
    Emmett L; Yin C; Crumbaker M; Hruby G; Kneebone A; Epstein R; Nguyen Q; Hickey A; Ihsheish N; O'Neill G; Horvath L; Chalasani V; Stricker P; Joshua AM, 2019, 'Rapid modulation of PSMA expression by androgen deprivation: Serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen blockade', Journal of Nuclear Medicine, vol. 60, pp. 950 - 954, http://dx.doi.org/10.2967/jnumed.118.223099
    Journal articles | 2019
    Dr Louise Emmett
    Crumbaker M; Emmett L; Horvath LG; Joshua AM, 2019, 'Exceptional response to 177lutetium prostate-specific membrane antigen in prostate cancer harboring DNA repair defects', JCO Precision Oncology, vol. 3, http://dx.doi.org/10.1200/PO.18.00237
    Journal articles | 2019
    Dr Louise Emmett
    Liu W; Fakir H; Randhawa G; Kassam Z; Chung HT; Chung P; Ward A; Zukotynski K; Emmett L; Bauman G, 2019, '2 Drive: Defining Radiorecurrent Intraprostatic Target Volumes', Radiotherapy and Oncology, vol. 139, pp. S4 - S4, http://dx.doi.org/10.1016/s0167-8140(19)33259-1
    Journal articles | 2019
    Dr Louise Emmett
    van Leeuwen PJ; Emmett L; Donswijk ML; Stricker PD; Pos FJ; Wit E; van der Poel HG, 2019, 'Early outcomes after [68Ga]PSMA-PET/CT guided salvage therapy in men with biochemical recurrence after radical prostatectomy', Tijdschrift voor Urologie, vol. 9, pp. 2 - 8, http://dx.doi.org/10.1007/s13629-018-00215-w
    Journal articles | 2018
    Dr Louise Emmett
    Lieng H; Hayden AJ; Christie DRH; Davis BJ; Eade TN; Emmett L; Holt T; Hruby G; Pryor D; Shakespeare TP; Sidhom M; Skala M; Wiltshire K; Yaxley J; Kneebone A, 2018, 'Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group', Radiotherapy and Oncology, vol. 129, pp. 377 - 386, http://dx.doi.org/10.1016/j.radonc.2018.06.027
    Journal articles | 2018
    Dr Louise Emmett
    Tan AC; Emmett L; Lo S; Liu V; Kapoor R; Carlino MS; Guminski AD; Long GV; Menzies AM, 2018, 'FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma', Annals of Oncology, vol. 29, pp. 2115 - 2120, http://dx.doi.org/10.1093/annonc/mdy330
    Journal articles | 2018
    Dr Louise Emmett
    Roach PJ; Francis R; Emmett L; Hsiao E; Kneebone A; Hruby G; Eade T; Nguyen QA; Thompson BD; Cusick T; McCarthy M; Tang C; Ho B; Stricker PD; Scott AM, 2018, 'The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study', Journal of Nuclear Medicine, vol. 59, pp. 82 - 88, http://dx.doi.org/10.2967/jnumed.117.197160
    Journal articles | 2018
    Dr Louise Emmett
    Byrne K; Eade T; Kneebone A; Guo L; Hsiao E; Schembri G; Kwong C; Hunter J; Emmett L; Hruby G, 2018, 'Delineating sites of failure following post-prostatectomy radiation treatment using 68Ga-PSMA-PET', Radiotherapy and Oncology, vol. 126, pp. 244 - 248, http://dx.doi.org/10.1016/j.radonc.2017.10.022
    Journal articles | 2018
    Dr Louise Emmett
    Pouliot F; Bauman G; Chua S; Davis I; Hicks R; Metser U; Punwani S; Scott A; Weickhardt A; Emmett L, 2018, 'PD37-02 A PROSPECTIVE MULTICENTER STUDY COMPARING MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP-MRI), F-18 FLUORO-METHYL-CHOLINE (FCH) AND GA-68 HBED-CC- (PSMA) POSITRON EMISSION TOMOGRAPHY IN PATIENTS BEING CONSIDERED FOR SALVAGE RADIATION THERAPY FOR BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY', Journal of Urology, vol. 199, http://dx.doi.org/10.1016/j.juro.2018.02.1737
    Journal articles | 2018
    Dr Louise Emmett
    Hope TA; Afshar-Oromieh A; Eiber M; Emmett L; Fendler WP; Lawhn-Heath C; Rowe SP, 2018, 'Imaging prostate cancer with prostate-specific membrane antigen PET/CT and PET/MRI: Current and future applications', American Journal of Roentgenology, vol. 211, pp. 286 - 294, http://dx.doi.org/10.2214/AJR.18.19957
    Journal articles | 2018
    Dr Louise Emmett
    Hruby G; Eade T; Emmett L; Ho B; Hsiao E; Schembri G; Guo L; Kwong C; Hunter J; Byrne K; Kneebone A, 2018, '68Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. 343 - 346, http://dx.doi.org/10.1111/ajco.12872
    Journal articles | 2018
    Dr Louise Emmett
    Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency', Journal of Clinical Immunology, vol. 38, pp. 159 - 162, http://dx.doi.org/10.1007/s10875-018-0477-z
    Journal articles | 2018
    Dr Louise Emmett
    2018, '2018 CUA Abstracts.', Can Urol Assoc J, vol. 12, pp. S51 - S136, https://www.ncbi.nlm.nih.gov/pubmed/29877793
    Journal articles | 2018
    Dr Louise Emmett
    Emmett L; Metzer U; Bauman G; Pouliot F; Hicks R; Chua S; Davis I; Punwani S; Weikhardt A; Scott A, 2018, 'Prospective, multinational comparison of magnetic resonance imaging (mp-MRI and WB–MRI) F-18 fluorocholine (FCH) and Ga-68 PSMA in high risk men being considered for salvage radiation treatment for biochemical failure post radical prostatectomy', European Urology Supplements, vol. 17, pp. e583 - e583, http://dx.doi.org/10.1016/s1569-9056(18)31246-6
    Journal articles | 2018
    Dr Louise Emmett
    Emmett L; Nandurkar R; Van Leeuwen P; Woo H; Kooner R; Ende D; O’Neill G; Yuen C; Ho B; Nguyen Q; Hickey A; Stricker P, 2018, 'Staging with Ga-68 HBED-CC-Glu-NH-CO-NH-Lys (Ahx) PSMA-11 PET CT (PSMA) prior to radical prostatectomy has high predictive value in assessing biochemical response to surgery', European Urology Supplements, vol. 17, pp. e1903 - e1903, http://dx.doi.org/10.1016/s1569-9056(18)32310-8
    Journal articles | 2017
    Dr Louise Emmett
    Fendler WP; Calais J; Allen-Auerbach M; Bluemel C; Eberhardt N; Emmett L; Gupta P; Hartenbach M; Hope TA; Okamoto S; Helmut Pfob C; Pöppel TD; Rischpler C; Schwarzenböck S; Stebner V; Unterrainer M; Zacho HD; Maurer T; Gratzke C; Crispin A; Czernin J; Herrmann K; Eiber M, 2017, '68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: An international multicenter prospective study', Journal of Nuclear Medicine, vol. 58, pp. 1617 - 1623, http://dx.doi.org/10.2967/jnumed.117.190827
    Journal articles | 2017
    Dr Louise Emmett
    Fanti S; Minozzi S; Morigi JJ; Giesel F; Ceci F; Uprimny C; Hofman MS; Eiber M; Schwarzenbock S; Castellucci P; Bellisario C; Chauvie S; Bergesio F; Emmett L; Haberkorn U; Virgolini I; Schwaiger M; Hicks RJ; Krause BJ; Chiti A, 2017, 'Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions', European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. 1622 - 1635, http://dx.doi.org/10.1007/s00259-017-3725-1
    Journal articles | 2017
    Dr Louise Emmett
    Stodell M; Thompson JF; Emmett L; Uren RF; Kapoor R; Saw RPM, 2017, 'Melanoma patient imaging in the era of effective systemic therapies', European Journal of Surgical Oncology, vol. 43, pp. 1517 - 1527, http://dx.doi.org/10.1016/j.ejso.2017.05.014
    Journal articles | 2017
    Dr Louise Emmett
    Holtkamp LHJ; Read RL; Emmett L; Thompson JF; Nieweg OE, 2017, 'Futility of imaging to stage melanoma patients with a positive sentinel lymph node', Melanoma Research, vol. 27, pp. 457 - 462, http://dx.doi.org/10.1097/CMR.0000000000000362
    Journal articles | 2017
    Dr Louise Emmett
    Calopedos RJS; Chalasani V; Asher R; Emmett L; Woo HH, 2017, 'Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: A systematic review and meta-analysis', Prostate Cancer and Prostatic Diseases, vol. 20, pp. 352 - 360, http://dx.doi.org/10.1038/pcan.2017.23
    Journal articles | 2017
    Dr Louise Emmett
    Emmett L; Willowson K; Violet J; Shin J; Blanksby A; Lee J, 2017, 'Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy', Journal of Medical Radiation Sciences, vol. 64, pp. 52 - 60, http://dx.doi.org/10.1002/jmrs.227
    Journal articles | 2017
    Dr Louise Emmett
    Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L, 2017, 'Frusemide aids diagnostic interpretation of 68Ga-PSMA positron emission tomography/CT in men with prostate cancer', Journal of Medical Imaging and Radiation Oncology, vol. 61, pp. 739 - 744, http://dx.doi.org/10.1111/1754-9485.12625
    Journal articles | 2017
    Dr Louise Emmett
    Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P, 2017, 'Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited', BJU International, vol. 120, pp. 673 - 681, http://dx.doi.org/10.1111/bju.13919
    Journal articles | 2017
    Dr Louise Emmett
    Hruby G; Eade T; Kneebone A; Emmett L; Guo L; Ho B; Hsiao E; Schembri G; Hunter J; Kwong C, 2017, 'Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer', Radiotherapy and Oncology, vol. 122, pp. 99 - 102, http://dx.doi.org/10.1016/j.radonc.2016.11.023
    Journal articles | 2017
    Dr Louise Emmett
    van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD, 2017, 'Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer', BJU International, vol. 119, pp. 209 - 215, http://dx.doi.org/10.1111/bju.13540
    Journal articles | 2017
    Dr Louise Emmett
    Long GV; Atkinson V; Menzies AM; Lo S; Guminski AD; Brown MP; Gonzalez MM; Diamante K; Sandhu SK; Scolyer RA; Emmett L; McArthur GA, 2017, 'A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC).', Journal of Clinical Oncology, vol. 35, pp. 9508 - 9508, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9508
    Journal articles | 2017
    Dr Louise Emmett
    Menzies AM; Gonzalez M; Guminski A; Nieweg O; Shannon K; Thompson JF; Kefford R; Ch'Ng S; Stretch J; Spillane AJ; Lee J; Lee H; Kapoor R; Emmett L; Rizos H; Saw RP; Scolyer RA; Long GV, 2017, 'Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma', Annals of Oncology, vol. 28, pp. v432 - v432, http://dx.doi.org/10.1093/annonc/mdx377.007
    Journal articles | 2017
    Dr Louise Emmett
    Gonzalez M; Menzies AM; Saw R; Thompson JF; Spillane AJ; Howle J; Nieweg O; Shannon K; Ch'Ng S; Stretch JF; Carlino MS; Guminski A; Emmett L; Rizos H; Scolyer RA; Long GV, 2017, 'A Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D+T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)', Annals of Oncology, vol. 28, pp. v445 - v445, http://dx.doi.org/10.1093/annonc/mdx377.041
    Journal articles | 2017
    Dr Louise Emmett
    Emmett L; Van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P, 2017, 'Treatment outcomes from 68Ga-PSMA PET/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: Prognostic value of a negative PSMA PET', Journal of Nuclear Medicine, vol. 58, pp. 1972 - 1976, http://dx.doi.org/10.2967/jnumed.117.196683
    Journal articles | 2016
    Dr Louise Emmett
    Tang R; Wang JTY; Wang L; Le K; Huang Y; Hickey AJ; Emmett L, 2016, 'Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis a systematic review and meta-analysis', Clinical Nuclear Medicine, vol. 41, pp. e327 - e339, http://dx.doi.org/10.1097/RLU.0000000000001063
    Journal articles | 2016
    Dr Louise Emmett
    Kanthan GL; Izard MA; Emmett L; Hsiao E; Schembri GP, 2016, 'Schwannoma showing avid uptake on 68Ga-PSMA-HBED-CC PET/CT', Clinical Nuclear Medicine, vol. 41, pp. 703 - 704, http://dx.doi.org/10.1097/RLU.0000000000001281
    Journal articles | 2016
    Dr Louise Emmett
    Lee P; Bova R; Schofield L; Bryant W; Dieckmann W; Slattery A; Govendir MA; Emmett L; Greenfield JR, 2016, 'Brown Adipose Tissue Exhibits a Glucose-Responsive Thermogenic Biorhythm in Humans', Cell Metabolism, vol. 23, pp. 602 - 609, http://dx.doi.org/10.1016/j.cmet.2016.02.007
    Journal articles | 2016
    Dr Louise Emmett
    Bhatia KD; Ambati C; Dhaliwal R; Paschkewitz R; Hsu E; Ho B; Young A; Emmett L, 2016, 'SPECT-CT/VQ versus CTPA for diagnosing pulmonary embolus and other lung pathology: Pre-existing lung disease should not be a contraindication', Journal of Medical Imaging and Radiation Oncology, vol. 60, pp. 492 - 497, http://dx.doi.org/10.1111/1754-9485.12471
    Journal articles | 2016
    Dr Louise Emmett
    Long GV; Atkinson V; Menzies AM; Guminski AD; Sandhu SK; Brown MP; Liaw T; Gonzalez M; Davison J; Paton EJ; Scolyer RA; Emmett L; McArthur GA, 2016, 'A randomized phase 2 study of nivolumab and nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases: The Anti-PD1 Brain Collaboration (ABC Study).', Journal of Clinical Oncology, vol. 34, pp. TPS9591 - TPS9591, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps9591
    Journal articles | 2016
    Dr Louise Emmett
    Van Leeuwen PJ; Emmett L; Hruby G; Kneebone A; Stricker P, 2016, '548 68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment', European Urology Supplements, vol. 15, pp. e548 - e548, http://dx.doi.org/10.1016/s1569-9056(16)60550-x
    Journal articles | 2016
    Dr Louise Emmett
    Van Leeuwen P; Emmett L; Ho B; Delprado W; Stricker P, 2016, '559 Prospective evaluation of 68Ga-PSMA positron emission tomography/computerized tomography for preoperative lymph node staging in prostate cancer', European Urology Supplements, vol. 15, pp. e559 - e559, http://dx.doi.org/10.1016/s1569-9056(16)60561-4
    Journal articles | 2015
    Dr Louise Emmett
    Morigi JJ; Stricker PD; Van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L, 2015, 'Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy', Journal of Nuclear Medicine, vol. 56, pp. 1185 - 1190, http://dx.doi.org/10.2967/jnumed.115.160382
    Journal articles | 2015
    Dr Louise Emmett
    Emmett L, 2015, '68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.', BJU International, vol. 117, pp. 732 - 739, http://dx.doi.org/10.1111/bju.13397
    Journal articles | 2015
    Dr Louise Emmett
    Wang LW; Omari A; Emmett L; Jansz PC; Huilgol R; Rainer S; Subbiah RN, 2015, 'Granulomatous sarcoid aortitis: A serious complication of a well-known multisystem disease', The Lancet, vol. 385, pp. 2014, http://dx.doi.org/10.1016/S0140-6736(15)60649-3
    Journal articles | 2015
    Dr Louise Emmett
    Emmett L, 2015, 'Prognostic and diagnostic implications of nonperfusion data on SPECT myocardial perfusion imaging', Current Cardiovascular Imaging Reports, vol. 8, pp. 1 - 9, http://dx.doi.org/10.1007/s12410-014-9307-8
    Journal articles | 2014
    Dr Louise Emmett
    Naehrig D; Uren RF; Emmett L; Ioannou K; Hong A; Wratten C; Thompson JF; Hruby G, 2014, 'Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: A pilot case series', Journal of Medical Imaging and Radiation Oncology, vol. 58, pp. 353 - 359, http://dx.doi.org/10.1111/1754-9485.12180
    Journal articles | 2014
    Dr Louise Emmett
    Sasson S; Smith S; Sewell WA; Morey A; Danta M; Emmett L; Kelleher AD; Fay K; Phan T, 2014, 'MONOCLONAL B-CELL POPULATION OF INDETERMINANT MALIGNANT POTENTIAL IN THE SETTING OF ATYPICAL CVID ASSOCIATED WITH LYMPHADENOPATHY AND SPLENOMEGALY', INTERNAL MEDICINE JOURNAL, vol. 44, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342722800109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2013
    Dr Louise Emmett
    Brungs D; Sze V; Emmett L; Epstein RJ, 2013, 'Complete Radiologic Response of Bulky Cerebral Metastases From Newly Diagnosed HER2-Positive Breast Cancer to Upfront Trastuzumab-Based Chemotherapy.', World J Oncol, vol. 4, pp. 122 - 125, http://dx.doi.org/10.4021/wjon639w
    Journal articles | 2012
    Dr Louise Emmett
    Emmett L; Ng A; Ha L; Russo R; Mansberg R; Zhao W; Chow SV; Kritharides L, 2012, 'Comparative assessment of rest and post-stress left ventricular volumes and left ventricular ejection fraction on gated myocardial perfusion imaging (MPI) and echocardiography in patients with transient ischaemic dilation on adenosine MPI: Myocardial stunning or subendocardial hypoperfusion?', Journal of Nuclear Cardiology, vol. 19, pp. 735 - 742, http://dx.doi.org/10.1007/s12350-012-9571-4
    Journal articles | 2012
    Dr Louise Emmett
    Emmett L, 2012, 'Disparate physical measurements of the left ventricle on concurrent Adenosine Myocardial Perfusion Imaging (MPI) and Echocardiography in patients with Transient ischaemic dilation and stunning of the left ventricle on MPI.', Journal of Nuclear Cardiology
    Journal articles | 2012
    Dr Louise Emmett
    Emmett L; Ho B, 2012, 'Imaging for melanoma and non-melanoma skin cancers', Cancer Forum, vol. 36
    Journal articles | 2011
    Dr Louise Emmett
    Girgis CM; Wong T; Ngu MC; Emmett L; Archer KA; Chen RC; Seibel MJ, 2011, 'Hypophosphataemic osteomalacia in patients on adefovir dipivoxil', Journal of Clinical Gastroenterology, vol. 45, pp. 468 - 473, http://dx.doi.org/10.1097/MCG.0b013e3181e12ed3
    Journal articles | 2010
    Dr Louise Emmett
    Chung SCS; Peters MJ; Chen S; Emmett L; Ing AJ, 2010, 'Effect of unilateral endobronchial valve insertion on pulmonary ventilation and perfusion: A pilot study', Respirology, vol. 15, pp. 1079 - 1083, http://dx.doi.org/10.1111/j.1440-1843.2010.01815.x
    Journal articles | 2010
    Dr Louise Emmett
    Wong T; Girgis CM; Ngu MC; Chen RCY; Emmett L; Archer KA; Seibel MJ, 2010, 'Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B', Journal of Clinical Endocrinology and Metabolism, vol. 95, pp. 479 - 480, http://dx.doi.org/10.1210/jc.2009-2051
    Journal articles | 2010
    Dr Louise Emmett
    Seccombe LM; Chung SCS; Jenkins CR; Frater CJ; Mackey DWJ; Pearson MA; Emmett L; Peters MJ, 2010, 'Lung perfusion and chest wall configuration is altered by glossopharyngeal breathing', European Respiratory Journal, vol. 36, pp. 151 - 156, http://dx.doi.org/10.1183/09031936.00163209
    Journal articles | 2010
    Dr Louise Emmett
    Russo RR; Ha L; Emmett L; Magee M; Mansberg R, 2010, 'Progressive visual loss due to obstruction of an optic nerve sheath fenestration demonstrated on SPECT/CT radionuclide cisternography', Clinical Nuclear Medicine, vol. 35, pp. 208 - 210, http://dx.doi.org/10.1097/RLU.0b013e3181cc647a
    Journal articles | 2010
    Dr Louise Emmett
    Russo RR; Emmett L; Mansberg R; Fung KC, 2010, 'Severe ischaemia on SPECT myocardial perfusion imaging secondary to microvascular dysfunction and apical hypertrophic cardiomyopathy', Clinical Nuclear Medicine, vol. 35, pp. 937 - 940, http://dx.doi.org/10.1097/RLU.0b013e3181f9de3c
    Journal articles | 2009
    Dr Louise Emmett
    Mansberg R; Nicholls M; Chan C; Emmett L; Van Der Wall H, 2009, 'Tuberculous epididymo-orchitis presenting as pyrexia of unknown origin during acute myeloid leukaemia consolidation therapy', Internal Medicine Journal, vol. 39, pp. 137 - 138, http://dx.doi.org/10.1111/j.1445-5994.2008.01866.x
    Journal articles | 2009
    Dr Louise Emmett
    Russo RR; Lee A; Mansberg R; Emmett L, 2009, 'Hypertrophic pulmonary osteoarthropathy demonstrated on SPECT/CT', Clinical Nuclear Medicine, vol. 34, pp. 628 - 631, http://dx.doi.org/10.1097/RLU.0b013e3181b06c9c
    Journal articles | 2009
    Dr Louise Emmett
    Ha L; Mansberg R; Van Der Wall H; Emmett L; Magee M, 2009, 'Increased in-111 octreotide uptake due to paget disease and a low midline pelvic kidney', Clinical Nuclear Medicine, vol. 34, pp. 84 - 86, http://dx.doi.org/10.1097/RLU.0b013e318192c4fc
    Journal articles | 2009
    Dr Louise Emmett
    Emmett L; Ng A; Russo R; Zhang W; Yong A; Freedman SB; Kritharides L, 2009, 'Transient Ischaemic Dilation on Tc99m Adenosine Myocardial Perfusion Imaging is not due to Left Ventricular Cavity Dilation or Stunning: Comparison of Echocardiography and Myocardial Perfusion Imaging', Heart, Lung and Circulation, vol. 18, pp. S44 - S44, http://dx.doi.org/10.1016/j.hlc.2009.05.096
    Journal articles | 2008
    Dr Louise Emmett
    Lee A; Emmett L; Van Der Wall H; Kannangara S; Mansberg R; Fogelman I, 2008, 'SPECT/CT of femeroacetabular impingement', Clinical Nuclear Medicine, vol. 33, pp. 757 - 762, http://dx.doi.org/10.1097/RLU.0b013e318187ef6b
    Journal articles | 2008
    Dr Louise Emmett
    Emmett L; Van Gaal WJ; Magee M; Bass S; Ali O; Freedman SB; Van der Wall H; Kritharides L, 2008, 'Prospective evaluation of the impact of diabetes and left ventricular hypertrophy on the relationship between ischemia and transient ischemic dilation of the left ventricle on single-day adenosine Tc-99m myocardial perfusion imaging', Journal of Nuclear Cardiology, vol. 15, pp. 638 - 643, http://dx.doi.org/10.1016/j.nuclcard.2008.06.005
    Journal articles | 2007
    Dr Louise Emmett
    Chung T; Emmett L; Mansberg R; Peters M; Kritharides L, 2007, 'Natural History of Right Ventricular Dysfunction After Acute Pulmonary Embolism', Journal of the American Society of Echocardiography, vol. 20, pp. 885 - 894, http://dx.doi.org/10.1016/j.echo.2006.12.005
    Journal articles | 2007
    Dr Louise Emmett
    Chung TS; Connor DE; Joseph JE; Emmett L; Mansberg R; Peters MW; Ma DD; Kritharides L, 2007, 'Platelet activation in acute pulmonary embolism', Journal of Thrombosis and Haemostasis, vol. 5, pp. 918 - 924, http://dx.doi.org/10.1111/j.1538-7836.2007.02461.x
    Journal articles | 2007
    Dr Louise Emmett
    Chung T; Connor D; Joseph J; Emmett L; Mansberg R; Ma D; Kritharides L, 2007, 'Shedding of P-selectin from Activated Platelets Correlates with the Severity of Right Ventricular Dysfunction During Acute Pulmonary Embolism', Heart, Lung and Circulation, vol. 16, pp. S61 - S61, http://dx.doi.org/10.1016/j.hlc.2007.06.157
    Journal articles | 2006
    Dr Louise Emmett
    Vu DH, 2006, 'Bone scintigraphy predicts outcome of steroid injection for plantar fasciitis', Journal of Nuclear Medicine, vol. 47, pp. 1577 - 1580
    Journal articles | 2006
    Dr Louise Emmett
    Chung T; Emmett L; Khoury V; Lau GT; Elsik M; Foo F; Allman KC; Kritharides L, 2006, 'Atrial and ventricular echocardiographic correlates of the extent of pulmonary embolism in the elderly', Journal of the American Society of Echocardiography, vol. 19, pp. 347 - 353, http://dx.doi.org/10.1016/j.echo.2005.09.012
    Journal articles | 2005
    Dr Louise Emmett
    Emmett L; Magee M; Freedman SB; Van Der Wall H; Bush V; Trieu J; Van Gaal W; Allman KC; Kritharides L, 2005, 'The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images', Journal of Nuclear Medicine, vol. 46, pp. 1596 - 1601
    Journal articles | 2005
    Dr Louise Emmett
    Emmett L, 2005, 'Electrocardiographic prediction of the severity of posterior wall perfusion defects on rest technetium-99m Sestamibi myocardial perfusion imaging.', Journal of Electrocardiology, vol. 38, pp. 195 - 203, http://dx.doi.org/10.1016/j.jelectrocard.2005.03.007
    Journal articles | 2004
    Dr Louise Emmett
    Trieu J; Emmett L; Perera C; Thanakrishnan K; Van Der Wall H, 2004, 'Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy', Clinical Nuclear Medicine, vol. 29, pp. 803 - 804, http://dx.doi.org/10.1097/00003072-200412000-00008
    Journal articles | 2003
    Dr Louise Emmett
    Emmett L; Husain M; Barolet A; Lee D; Iwanochko MR, 2003, 'Attenuation correction of ECG-gated TC-99 m sestamibi myocardial perfusion imaging impairs the detection of triple vessel disease on coronary angiography', Heart, Lung and Circulation, vol. 12, pp. A33 - A33, http://dx.doi.org/10.1046/j.1443-9506.2003.01521.x
    Journal articles | 2002
    Dr Louise Emmett
    Frater C; Emmett L; Van Gaal W; Sungaran J; Devakumar D; Van Der Wall H, 2002, 'A Critical Appraisal of Pinhole Scintigraphy of the Ankle and Foot', Clinical Nuclear Medicine, vol. 27, pp. 707 - 710, http://dx.doi.org/10.1097/00003072-200210000-00005
    Journal articles | 2002
    Dr Louise Emmett
    Emmett L, 2002, 'Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses.', J Am Coll Cardiol, vol. 39, pp. 991 - 998, http://dx.doi.org/10.1016/S0735-1097(02)01707-2
    Journal articles | 2001
    Dr Louise Emmett
    Chicco P; Magnussen JS; Mackey DW; Bush V; Emmett L; Storey G; Bautovich G; Van Der Wall H, 2001, 'SPET of a computerised model of diffuse lung disease', European Journal of Nuclear Medicine, vol. 28, pp. 150 - 154, http://dx.doi.org/10.1007/s002590000425
    Journal articles | 2001
    Dr Louise Emmett
    EMMETT L; IWANOCHKO R; BAROLET A; HUSAIN M, 2001, '2.4 Correlation of rest-stress gated SPECT determined regional wall motion abnormalities with coronary angiographic stenoses', Journal of Nuclear Cardiology, vol. 8, pp. S16 - S16, http://dx.doi.org/10.1016/s1071-3581(01)80492-x
    Journal articles | 2000
    Dr Louise Emmett
    Magee M; Kannangara S; Dennien B; Lonergan R; Emmett L; Van Der Wall H, 2000, 'Paraspinal abscess complicating facet joint injection', Clinical Nuclear Medicine, vol. 25, pp. 71 - 73, http://dx.doi.org/10.1097/00003072-200001000-00024
    Journal articles | 2000
    Dr Louise Emmett
    Emmett L; Allman KC, 2000, 'Eikenella corrodens vertebral osteomyelitis', Clinical Nuclear Medicine, vol. 25, pp. 1059 - 1060, http://dx.doi.org/10.1097/00003072-200012000-00032
    Journal articles | 2000
    Dr Louise Emmett
    Breit R; Van Der Wall H; Emmett L; Storey G; Allman K, 2000, 'Sunburst periosteal reaction in a bony metastasis', Clinical Nuclear Medicine, vol. 25, pp. 392 - 393, http://dx.doi.org/10.1097/00003072-200005000-00025
    Journal articles | 2000
    Dr Louise Emmett
    Emmett L; Storey G; Marel E; Van Der Wall H, 2000, 'Sequestered collection in association with infected arthroplasty', Clinical Nuclear Medicine, vol. 25, pp. 288 - 289, http://dx.doi.org/10.1097/00003072-200004000-00011
    Journal articles | 1999
    Dr Louise Emmett
    Tejani A; Stablein DM; Donaldson L; Harmon WE; Alexander SR; Kohaut E; Emmett L; Fine RN, 1999, 'Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience.', Clin Transpl, pp. 95 - 110, https://www.ncbi.nlm.nih.gov/pubmed/11038628
    Journal articles | 1999
    Dr Louise Emmett
    Van der Wall H; Storey G; Emmett L; Magee M, 1999, 'Pain in the anterior pelvis and postoperative prostatectomy findings', Clinical Nuclear Medicine, vol. 24, pp. 523 - 524, http://dx.doi.org/10.1097/00003072-199907000-00013
    Journal articles | 1999
    Dr Louise Emmett
    Emmett LM; Patel NC; Thanakrishnan K; Van Der Wall H; Magee M; Allman KC, 1999, 'Extensive rhabdomyolysis after streptokinase therapy for acute myocardial infarction demonstrated by Tc-99m PYP scintigraphy', Clinical Nuclear Medicine, vol. 24, pp. 991 - 992, http://dx.doi.org/10.1097/00003072-199912000-00024
  • Conference Papers | 2021
    Dr Louise Emmett
    Emmett L; Subramaniam S; Zhang AY; Martin AJ; Yip S; Crumbaker M; Rana N; Ford K; Langford A; Francis RJ; Hofman MS; Joshua AM; Sandhu SK; Azad A; Gedye C; McJannett MM; Stockler MR; Davis ID, 2021, 'ENZA-p: A randomized phase II trial using PSMA as a therapeutic agent and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.TPS177
    Conference Papers | 2021
    Dr Louise Emmett
    Hofman MS; Emmett L; Sandhu SK; Iravani A; Joshua AM; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Ng S; Francis RJ; Gedye C; Rutherford NK; Zhang AY; McJannett MM; Stockler MR; Violet JA; Williams S; Martin AJ; Davis ID, 2021, '177Lu-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel: Updated results including progression-free survival (PFS) and patient-reported outcomes (PROs) (TheraP ANZUP 1603).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.6
    Conference Papers | 2021
    Dr Louise Emmett
    Azad A; Dhiantravan N; Emmett L; Joshua AM; Vela I; Pattison DA; Francis RJ; Williams S; Sandhu SK; Davis ID; Neha N; Bressel M; Murphy DG; Hofman MS, 2021, 'UpFrontPSMA: A randomized phase II study of sequential 177Lu-PSMA617 and docetaxel versus docetaxel in metastatic hormone-naive prostate cancer (mHNPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.TPS180
    Conference Papers | 2021
    Dr Louise Emmett
    Pathmanandavel S; Crumbaker M; Yam AOW; Rofe C; Ho B; Chan WL; Sharma S; Hickey AJ; Kongrak K; Ratnayake L; Kwan EM; Azad A; Eu P; Nguyen A; Joshua AM; Emmett L, 2021, 'Final results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and NOX66 in men with end-stage metastatic castration-resistant prostate cancer (LuPIN trial)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.103
    Conference Papers | 2020
    Dr Louise Emmett
    Emmett L; Pathmanandavel S; Crumbaker M; Rofe C; Yam AOW; Ho B; Chan WL; Sharma S; Keane J; Hickey AJ; Fullard K; Kongrak K; Ratnayake L; Violet JA; Azad A; Eu P; Nguyen A; Joshua AM, 2020, 'Updated results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination Lu-177 PSMA 617 and idronoxil in men with mCRPC post androgen signalling inhibition and taxane chemotherapy (LuPIN trial).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368302400&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Dr Louise Emmett
    Hofman MS; Emmett L; Sandhu SK; Iravani A; Joshua AM; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Ng S; Francis RJ; Gedye C; Rutherford NK; Zhang AY; McJannett MM; Stockler MR; Violet JA; Williams S; Martin AJ; Davis ID, 2020, 'TheraP: A randomised phase II trial of Lu-177-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration resistant prostate cancer (mCRPC) progressing after docetaxel: Initial results (ANZUP protocol 1603).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368302345&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Dr Louise Emmett
    Emmett L; Pathmanandavel S; Nguyen A; Crumbaker M; Yam AOW; Chan WL; Fullard K; Ho B; Azad A; Joshua AM, 2020, 'Results of a phase I/II prospective dose-escalation trial evaluating safety and efficacy of combination 177LuPSMA-617 and NOX66 in men with mCRPC post androgen signalling inhibition and two lines of taxane chemotherapy (LuPIN trial)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, presented at Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA, 13 February 2020 - 15 February 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000529525900189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Louise Emmett
    Amin A; Ende J; Stricker P; Emmett L, 2020, 'Pilot trial comparing the performance of 68Ga-PSMA-11 PET/CT to 18F-PSMA-1007 PET/CT in the detection of prostate cancer recurrence in men with rising PSA following radical prostatectomy', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 27, pp. 112 - 112, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000585265700272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Louise Emmett
    Amin A; Blazevski A; Thompson J; Van Leeuwen P; Emmett L; Stricker P, 2020, 'Early Cases from the DETECT trial: Radioguided Surgery with Technetium99 m-labelled PSMA to aid Intraoperative Lymph Node Metastases Detection for Patients Undergoing Radical Prostatectomy and ePLND for Prostate Cancer', in BJU INTERNATIONAL, WILEY, Sydney, AUSTRALIA, Vol. 125, pp. 86 - 87, presented at 73rd Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand, Sydney, AUSTRALIA, 07 March 2020 - 10 March 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518206100169&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Louise Emmett
    Roberts M; Tariq A; Morton A; Donato P; Kyle S; Pattison D; Thomas P; Geoff C; Esler R; Dunglison N; Gardiner R; Doi S; Emmett L; Yaxley J, 2020, 'Improved prostate cancer detection and prediction of outcomes using 68Ga PSMA PET/CT: towards non-invasive precision medicine.', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 16, pp. 42 - 43, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000594482700023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Dr Louise Emmett
    Gondoputro W; Amin A; Blazevski A; Scheltema M; Van Leeuwen P; Van Leeuwen F; Thompson J; Emmett L; Stricker P, 2020, '99m-technetium-labelled PSMA radioguided surgery for the intraoperative detection of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for prostate cancer: preliminary cases from the DETECT trial', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, Vol. 27, pp. 115 - 115, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000585265700282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Louise Emmett
    Hofman M; Emmett L; Violet JA; Lawrence NJ; Williams S; Stockler MR; Francis RJ; Iravani A; Zhang AY; Martin AJ; Azad A; Yip S; Langford A; McJannett MM; Davis ID, 2019, 'TheraP: A randomized phase II trial of [Lu-177]-PSMA-617 theranostic versus cabazitaxel in progressive metastatic castration-resistant prostate cancer', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 37, presented at ASCO-SITC Clinical Immuno-Oncology Symposium, San Francisco, CA, 28 February 2019 - 02 March 2019, http://dx.doi.org/10.1200/JCO.2019.37.7_suppl.TPS332
    Conference Abstracts | 2019
    Dr Louise Emmett
    Emmett L; Crumbaker M; Nguyen A; Ho B; Yin C; Isheish N; Azad A; Violet J; Sharma S; Joshua A, 2019, 'Interim results of a Phase I/II prospective dose escalation trial evaluating safety and efficacy of combination Lu-177 PSMA 617 and NOX66 in men with mCRPC post androgen signalling inhibition and 2 lines of taxane chemotherapy (LuPIN trial)', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Anaheim, CA, Vol. 60, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Anaheim, CA, 22 June 2019 - 25 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000473116800464&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Louise Emmett
    Liu W; Fakir H; Randhawa G; Kassam Z; Chung HT; Chung P; Ward A; Zukotynski K; Emmett L; Bauman GS, 2019, 'DRIVE: Defining Radiorecurrent Intraprostatic Target Volumes', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, Chicago, IL, Vol. 105, pp. E291 - E291, presented at 61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Chicago, IL, 15 September 2019 - 18 September 2019, http://dx.doi.org/10.1016/j.ijrobp.2019.06.1834
    Conference Abstracts | 2019
    Dr Louise Emmett
    Ardolino L; Tang R; Pathmanandavel S; Crumbaker M; Joshua A; Emmett L, 2019, 'Lu-177-PSMA-617 as monotherapy or in combination with NOX66 for the treatment of men with late-stage metastatic castrate resistant prostate cancer (mCRPC): An exploratory analysis', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 115 - 115, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Louise Emmett
    Emmett L; Chalasani V; Kneebone A; Hruby G; Joshua AM, 2019, 'Rapid modulation of PSMA expression by ADT: Serial PSMA PET in men commencing androgen blockade.', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, Milan, ITALY, Vol. 133, pp. S445 - S446, presented at 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, ITALY, 26 April 2019 - 30 April 2019, http://dx.doi.org/10.1016/S0167-8140(19)31267-8
    Conference Abstracts | 2019
    Dr Louise Emmett
    Long GV; Atkinson VG; Lo S; Sandhu SK; Brown M; Gonzalez M; Guminski A; Scolyer RA; Emmett L; Menzies AM; McArthur GA, 2019, 'Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo plus ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 brain collaboration (ABC)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Barcelona, SPAIN, Vol. 30, pp. 534 - 534, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 27 September 2019 - 01 October 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295503357&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Louise Emmett
    Amin A; Stricker P; Scheltema M; Blazevski A; Chang J; van Leeuwen P; Quoc N; Ho B; Delprado W; Lee J; Cusick T; Spriensma A; Siriwardena A; O'Neill G; Yuen C; Kooner R; Hruby G; Thompson J; Emmett L, 2019, 'Diagnostic Accuracy of 68GA-PSMA PET and MPMRI to Detect Intra-Prostatic Clinically Significant Prostate Cancer Using Whole-Mount Pathology. Impact of the Addition of 68GA-PSMA PET to MPMRI?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 42 - 42, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000476915200018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Louise Emmett
    Liu W; Fakir H; Randhawa G; Kassam Z; Chung HT; Chung P; Ward A; Zukotynski K; Emmett L; Bauman G, 2019, 'DRIVE: DEFINING RADIORECURRENT INTRAPROSTATIC TARGET VOLUMES', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, Halifax, CANADA, Vol. 139, pp. S4 - S4, presented at Annual Scientific Meeting of the Canadian-Association-for-Radiation-Oncology (CARO), Halifax, CANADA, 02 October 2019 - 05 October 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493893300003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Dr Louise Emmett
    Metser U; Chua S; Ho B; Punwani S; Johnston E; Pouliot F; Tau N; Hawsawy A; Anconina R; Bauman G; Hicks R; Weickhardt A; Davis I; Pond G; Scott A; Emmett L, 2019, 'The contribution of multiparametric pelvic and whole body MR to the interpretation of F-18-fluoromethylcholine(FCH) or Ga-68-HBED-CC PSMA-11 (PSMA) PET/CT in the detection of pelvic recurrence or distant metastases in patients with biochemical failure following radical prostatectomy.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Anaheim, CA, Vol. 60, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Anaheim, CA, 22 June 2019 - 25 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000473116800591&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Dr Louise Emmett
    Gonzalez M; Menzies AM; Saw R; Spillane AJ; Nieweg OE; Shannon KF; Thompson JF; Howle JR; Ch'ng S; Stretch J; Osorio M; Emmett L; Rizos H; Guminski AD; Carlino MS; Scolyer RA; Long GV, 2018, 'Determining optimal sequencing of anti-PD-1 and BRAF-targeted therapy: A phase II randomised study of neoadjuvant pembrolizumab with/without dabrafenib and trametinib (D plus T) in BRAF V600 mutant resectable stage IIIb/c/d melanoma (NeoTrio trial)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS9604
    Conference Papers | 2018
    Dr Louise Emmett
    Tan AC; Emmett L; Lo S; Liu V; Guminski AD; Long GV; Menzies AM, 2018, 'Utility of 1-year FDG-PET (PET) to determine outcomes from anti-PD-1 (PD1) based therapy in patients (pts) with metastatic melanoma (MM)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.9517
    Conference Papers | 2018
    Dr Louise Emmett
    Crumbaker M; Joshua AM; Epstein R; Emmett L, 2018, 'A phase I study of Lu-177-DKFZ PSMA 617 combined with the radiosensitizer idronoxil in men with metastatic castrate-resistant prostate cancer (mCRPC) (LuPin trial).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS5088
    Conference Papers | 2018
    Dr Louise Emmett
    Bauman GS; Metser U; Scott A; Pouliot F; Weickhardt A; Davis I; Hicks R; Punwani S; Chua S; Emmett L, 2018, 'A Prospective Study of F-18 Fluoro-methyl-choline (FCH) And Ga-68 HBED-CC- (PSMA) in Men being Considered for Salvage Radiation Treatment for Biochemical Failure Post Radical Prostatectomy', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, San Antonio, TX, pp. S162 - S162, presented at 60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio, TX, 21 October 2018 - 24 October 2018, http://dx.doi.org/10.1016/j.ijrobp.2018.07.016
    Conference Abstracts | 2018
    Dr Louise Emmett
    Liu W; Chung HT; Chung P; Zukotynski K; Metser U; Rachinsky I; Wolfson R; Archer S; Emmett L; Bauman GS, 2018, 'Advanced Prostate Imaging of Recurrent Cancer after Radiation Therapy (PICs): Interim Results of a Prospective, Multi-Center Trial', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, San Antonio, TX, Vol. 102, pp. E126 - E126, presented at 60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San Antonio, TX, 21 October 2018 - 24 October 2018, http://dx.doi.org/10.1016/j.ijrobp.2018.07.337
    Conference Papers | 2018
    Dr Louise Emmett
    Emmett L; Metser U; Bauman G; Hicks R; Pouliot F; Davis I; Chua S; Weickhardt A; Punwani S; Ho B; Johnston E; Scott A, 2018, 'A prospective, multinational comparison of multi-parametric and whole body magnetic resonance imaging (mp-MRI and WB-MRI) F-18 fluoro-methyl-choline (FCH) and Ga-68 HBED-CC-(PSMA) in high risk men being considered for salvage radiation treatment for biochemical failure post radical prostatectomy: Detection rates, management impact and treatment response.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Philadelphia, PA, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Philadelphia, PA, 23 June 2018 - 26 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467489900457&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Dr Louise Emmett
    Emmett L; Joshua A; Epstein R; Chalasani V; Kneebone A; Hruby G; O'Neill G; Stricker P; Stricker P; Quoc N; Ho B, 2018, 'Modulation of PSMA expression by Androgen deprivation therapy (ADT): Serial PSMA PET in men with hormone sensitive, and castrate resistant prostate cancer commencing androgen blockade', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Philadelphia, PA, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Philadelphia, PA, 23 June 2018 - 26 June 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467489900093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Dr Louise Emmett
    Gielchinsky I; Chang J; Emmett L; Scheltema M; Stricker P; Nguyen Q; Delprado W, 2018, 'False positive intraprostatic lesions on 68 Ga Positron emission tomography in an intermediate prostate cancer cohort: description of a benign cystic cellular pattern with intense PSMA activity', in BJU INTERNATIONAL, WILEY, Melbourne, AUSTRALIA, Vol. 121, pp. 74 - 75, presented at 71st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Melbourne, AUSTRALIA, 24 February 2018 - 27 February 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000425625700159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Louise Emmett
    Gonzalez M; Menzies AM; Saw R; Thompson JF; Spillane AJ; Howle J; Nieweg O; Shannon K; Ch'Ng S; Stretch JF; Carlino MS; Guminski A; Emmett L; Rizos H; Scolyer RA; Long GV, 2017, 'A Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D plus T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Madrid, SPAIN, presented at 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, SPAIN, 08 September 2017 - 12 September 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324003119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Louise Emmett
    Menzies AM; Gonzalez M; Guminski A; Nieweg O; Shannon K; Thompson JF; Kefford R; Ch'Ng S; Stretch J; Spillane AJ; Lee J; Lee H; Kapoor R; Emmett L; Rizos H; Saw RP; Scolyer RA; Long GV, 2017, 'Phase 2 study of neoadjuvant dabrafenib plus trametinib (D plus T) for resectable stage IIIB/C BRAF V600 mutant melanoma', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, Madrid, SPAIN, presented at 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, SPAIN, 08 September 2017 - 12 September 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324003085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Dr Louise Emmett
    Siriwardana A; Thompson J; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes A-M; Coughlin G; Stricker P, 2017, 'Robot-assisted salvage node dissection for oligometastatic nodal disease detected by 68gallium-PSMA PET/CT: a multicentre retrospective series', in BJU INTERNATIONAL, WILEY-BLACKWELL, Canberra, AUSTRALIA, Vol. 119, pp. 78 - 79, presented at 70th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Canberra, AUSTRALIA, 24 February 2017 - 27 February 2017, http://dx.doi.org/10.1016/j.juro.2017.02.1661
    Conference Posters | 2017
    Dr Louise Emmett
    Joshua AM; Stricker P; Epstein RJ; Ho B; Quoc N; Kent R; Willowson KP; Hofman M; Violet JA; Emmett L, 2017, 'Patterns of failure on Ga PSMA (GaPSMA) and F18 FDG (FDG) PET CT in a prospective phase 2 trial of Lu-177 DKFZ PSMA 617 (LuPSMA) in men with castrate resistant metastatic prostate cancer (mCRPC)', Chicago, IL, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Chicago, IL, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.2562
    Conference Papers | 2017
    Dr Louise Emmett
    Calopedos R; Chalasani V; Asher R; Emmett L; Woo H, 2017, 'Lutetium-177 labelled prostate-specific membrane antigen (PSMA) for metastatic castrate-resistant prostate cancer (MCRPC): a systematic review and meta-analysis', in INTERNATIONAL JOURNAL OF UROLOGY, WILEY, pp. 110 - 110, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406683600308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Louise Emmett
    Calopedos R; Chalasani V; Asher R; Emmett L; Woo HH, 2017, 'LUTETIUM-177 LABELLED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY AND LIGANDS FOR THE TREATMENT OF METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (MCRPC): A SYSTEMATIC REVIEW AND META-ANALYSIS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 41 - 42, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427541700048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Louise Emmett
    Fennessy N; Emmett L; Lee J, 2017, 'Frusemide aids diagnostic interpretation of Ga-68-PSMA PET CT in men with Prostate cancer.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Denver, CO, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Denver, CO, 10 June 2017 - 14 June 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404949905077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Louise Emmett
    Emmett L; Lee J; Tang R; Ho B, 2017, 'Impact of small node size on clinical interpretation of F18 FDG PET CT for primary head and neck SCC malignancy. Bad things can come in small packages.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Denver, CO, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Denver, CO, 10 June 2017 - 14 June 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404949901025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Dr Louise Emmett
    Roach P; Francis R; Emmett L; McCarthy M; Scott A, 2017, 'Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre study', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, Denver, CO, Vol. 58, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Denver, CO, 10 June 2017 - 14 June 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404949903106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Dr Louise Emmett
    Holtkamp LHJ; Chakera A; Fung S; Stretch J; Saw R; Lee K; Gonzalez M; Thompson J; Emmett L; Nieweg OE, 2017, 'Staging F-18-FDG PET/CT Influences the Melanoma Treatment Plan in Patients with (Micro) Satellites or In-Transit Metastases', in ANNALS OF SURGICAL ONCOLOGY, SPRINGER, Seattle, WA, pp. S131 - S131, presented at 70th Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), Seattle, WA, 15 March 2017 - 18 March 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435672100355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2016
    Dr Louise Emmett
    Roach P; Francis R; Emmett L; Hsiao E; Kneebone A; Hruby G; Eade T; Nguyen Q; Thompson B; McCarthy M; Tang C; Brenner P; Stricker P; Scott A, 2016, 'Australian multicentre evaluation of clinical management intent utilising Ga68-PSMA PET scans in patients with prostate cancer', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, Barcelona, SPAIN, pp. S165 - S165, presented at Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, SPAIN, 15 October 2016 - 19 October 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391801600404&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Louise Emmett
    Zhang LF; Emmett L; Milner B; Belousova N; Clifford L; Havryk A; Stone E, 2015, 'Pilot introduction of the IASLC nodal classification system across EBUS-TBNA, CT and PET in staging of Non Small Cell Lung Cancer', in JOURNAL OF THORACIC ONCOLOGY, ELSEVIER SCIENCE INC, pp. S681 - S681, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370365103281&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Louise Emmett
    Ali SA; Emmett L; Wang J; Van Leeuwen P; Stark D; Morigi J; Stricker P, 2015, 'A comparison of the utility of F18 Choline and Ga68 PSMA PET/CT in identifying distant disease in high risk prostate cancer patients being considered for radical prostatectomy', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, Hamburg, GERMANY, pp. S380 - S380, presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, GERMANY, 10 October 2015 - 14 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363013202257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Louise Emmett
    Morigi J; Stricker P; van Leeuwen P; Tang R; Ho B; Nguyen Q; Hickey A; Stark D; Young A; Fanti S; Tarlinton L; Emmett L, 2015, 'Prospective Comparison of the detection rate of 18F-Fluoromethylcholine and 68Ga-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative intent therapy, being considered for targeted therapy', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, Hamburg, GERMANY, pp. S35 - S36, presented at 28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, GERMANY, 10 October 2015 - 14 October 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363013201051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Louise Emmett
    van Leeuwen P; Stricker P; Morigi JJ; Quoc N; Kneebone A; Emmett L, 2015, 'Prospective comparison of the detection rate of F-18-Fluoromethylcholine and Ga-68-PSMA-HBED PET/CT in men with prostate cancer with rising PSA post curative treatment, being considered for targeted therapy', in BJU INTERNATIONAL, WILEY, Cairns, AUSTRALIA, pp. 29 - 29, presented at 2nd Prostate Cancer World Congress (PCWC), Cairns, AUSTRALIA, 17 August 2015 - 21 August 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359254200081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Louise Emmett
    Emmett L, 2015, 'PET-PSMA IN PROSTATE CANCER: CHANGING OUR VIEW OF METASTATIC DISEASE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Sydney, AUSTRALIA, pp. 30 - 30, presented at ANZUP Annual Scientific Meeting on Redefining Personalised Medicine, Sydney, AUSTRALIA, 12 July 2015 - 14 July 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362808000028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Dr Louise Emmett
    Slattery A; Le K; Emmett L; Young A, 2015, 'USING COMPUTER VISION FOR DETERMINING BONE INVOLVEMENT FOR LYMPHOMA PATIENTS WITH PET-CT IMAGES', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 2 - 2, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353038000005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Dr Louise Emmett
    Clack M; Emmett L; Szeto E; Chan L; Ho B, 2014, 'ATTENUATION CORRECTION IN MYOCARDIAL PERFUSION IMAGING: A COMPARATIVE STUDY BETWEEN PRONE AND CTAC', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 19 - 19, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334282000053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Dr Louise Emmett
    Droguett-Fuhrer N; Emmett L; Russo R; Al Cheikh E; Sorensen N, 2012, 'QUANTITATIVE ANALYSIS OF BLOOD POOL SPECT IMAGES IN THE EVALUATION OF THE SACROILIAC JOINTS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 37 - 37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307882100121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Dr Louise Emmett
    Al Cheikh E; Emmett L; Russo R, 2012, 'A COMPARATIVE EVALUATION OF PLANAR VS SPECT/CT IN THE ASSESSMENT OF SACROILIAC JOINT ACTIVITY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 37 - 37, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307882100120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Dr Louise Emmett
    Sorensen N; Emmett L; Tow J, 2012, 'DETERMINING APPROPRIATE PROCESSING METHOD FOR SPECT DATA OF LYMPHOSCINTIGRAPHY SCANNING', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 6 - 6, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307882100018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Dr Louise Emmett
    Frater C; Mackey D; Emmett L; Van der Wall H, 2011, 'CALARA - Compassionate ALARA', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, pp. S448 - S448, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208619401785&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Dr Louise Emmett
    Frater C; Seccombe L; Chung S; Pearson M; Mackey D; Russo R; Emmett L, 2011, 'Glossopharyngeal breathing causes lung perfusion changes in Extreme Breath Hold Divers', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, pp. S458 - S459, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208619401833&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Dr Louise Emmett
    Al Cheikh E; Emmett L; Russo R; Mansberg R; Magee M; Yung G, 2011, 'DEVELOPMENT OF AN AGE AND SEX MATCHED NORMAL DATABASE FOR QUANTITATIVE SACROILIAC UPTAKE ON SPECT/CT Tc-99m-MDP BONE IMAGING', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 24 - 24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000292514200075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Dr Louise Emmett
    Emmett L; Ng A; Sorensen N; Mansberg R; Kritharides L, 2011, 'Transient Ischaemic Dilation on Tc99m Adenosine Myocardial perfusion Imaging is not due to left ventricular cavity dilation or stunning. Comparison of echocardiography and myocardial perfusion imaging', in EUROPEAN HEART JOURNAL SUPPLEMENTS, OXFORD UNIV PRESS, Amsterdam, NETHERLANDS, pp. A59 - A59, presented at 10th International Conference of Non-Invasive Cardiovascular Imaging, Amsterdam, NETHERLANDS, 15 May 2011 - 18 May 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291748800165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2006
    Dr Louise Emmett
    Chung T; Connor D; Joseph J; Emmett L; Ma D; Kritharides L, 2006, 'Platelet activation, inflammation and cardiac dysfunction, and their relation to the extent of acute pulmonary embolism', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 295 - 295, presented at 28th Congress of the European-Society-of-Cardiology/World Congress of Cardiology, Barcelona, SPAIN, 02 September 2006 - 06 September 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240668402012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2006
    Dr Louise Emmett
    Chung T; Emmett L; Kritharides L, 2006, 'Reduced tricuspid annular motion and right ventricular myocardial tissue velocities predict the extent and resolution of acute pulmonary embolism', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, Barcelona, SPAIN, pp. 616 - 616, presented at 28th Congress of the European-Society-of-Cardiology/World Congress of Cardiology, Barcelona, SPAIN, 02 September 2006 - 06 September 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240668404188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2001
    Dr Louise Emmett
    Emmett L; Husain M; Barolet A; Freeman M; Iwanochko RM, 2001, 'A reversible regional wall motion abnormality on single day exercise Tc-99m sestamibi gated SPECT perfusion: Imaging predicts a high grade angiographic stenosis.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, pp. 94P - 95P, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000168821900354&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2000
    Dr Louise Emmett
    Van der Wall H; Magee M; Emmett L; Bruce W, 2000, 'A new appraoch to the diagnosis of fat embolism.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, pp. 326P - 326P, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089892401309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 1999
    Dr Louise Emmett
    Van der Wall H; Magee M; Magnussen J; Emmett L; Frater C; Murray P, 1999, 'A novel view for the scintigraphic assessment of the elbow.', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, pp. 194P - 194P, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000080105800785&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Awards

Grants

Research Support (ongoing and completed last 3 years only)

 

2018-2020: CI CINSW grant for Prostate cancer imaging, genomic and theranostics research $3.75m

 

2017-2019: AI CINSW grant:  Computed tomography (CT) and positron emission tomography (PET)/CT surveillance imaging in asymptomatic Stage III melanoma patients - a prospective cohort study of clinical

benefit and economic implications $500k.

 

2014-2018: CI Gap2 Movember Grant for PROPS trial : International prospective imaging trial in BCR post RP with MRI, F18 FCH and Ga PSMA.$1.65m

 

2016-2018: CI Paul Ramsay Foundation Grant for Prospective Lu PSMA trial (completed and in submission) $500K.

 

2018-2020: AI ANZUP/PCFA/Movember grant $1.5m: TheraP phase II trial – prospective multisite randomized trial comparing LuPSMA vs Cabazitaxel.

 

2017-2019: CI: Noxopharm funding for prospective phase 1 dose escalation  trial in LuPSMA + NOX66 (radiation sensitizer) $ 900K

 

Media